🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Argentina's Bioceres expands global seed tie-up with Syngenta

Published 09/16/2022, 02:30 PM
Updated 09/16/2022, 02:37 PM
© Reuters. A logo is seen at the headquarters of agricultural chemical maker Syngenta in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann

BUENOS AIRES (Reuters) - Argentine seed technology firm Bioceres said on Friday it had agreed to expand its collaboration with Swiss seeds and pesticides maker Syngenta to develop and market its biological seed treatment solutions globally.

The deal between the two firms, which already partner in Argentina, would see Syngenta become the exclusive commercial distributor of these products globally and work on research and development of new products with Bioceres.

Bioceres develops biological products that help improve crop nutrition and cut down the need for nitrogen fertilizers. It also has a range of drought-resistant crops, though they will not be part of the deal.

Syngenta, which is planning a $10 billion initial public offering, was bought in 2017 for $43 billion by ChemChina, which was folded into Sinochem Holdings Corp last year.

© Reuters. A logo is seen at the headquarters of agricultural chemical maker Syngenta in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann

Bioceres said the two firms would expand their cooperation in markets such as Brazil and China, as well as other regions around the world.

"Biological products play an important role in offering growers new solutions to increase crop yields while reducing agriculture's environmental footprint," Bioceres Chief Executive Officer Federico Trucco said in a statement.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.